The ability to experience pleasurable sexual activity is important for human health.
Receptive anal intercourse (RAI) is a common, though frequently stigmatized, pleasurable …

Current management of locally advanced rectal cancer achieves high cure rates, distant
metastatic spread being the main cause of patients' death. Total neoadjuvant therapy (TNT) …

The therapeutic landscape in locally advanced rectal cancer (LARC) has undergone a
significant paradigm shift in recent years with the rising adoption of total neoadjuvant …

In 2023, colorectal cancer (CRC) is the third most diagnosed malignancy and the third
leading cause of cancer death worldwide. At the time of the initial visit, 20% of patients …

Radiotherapy and chemotherapy are effective treatments for patients with locally advanced
rectal cancer (LARC) and can significantly improve the likelihood of R0 resection …

Background/Aim: The role of neoadjuvant radiotherapy in the management of patients with
locally advanced rectal cancer (LARC) who have undergone neoadjuvant systemic therapy …

Extraordinary advances in cancer screening, therapeutics, and supportive care have
contributed to substantial progress in survival rates among patients with cancer over the last …

Background Pelvic exenteration (PE) is often the only curative treatment option for selected
locally advanced and locally recurrent colorectal cancer associated with significant …

Simple Summary This survey study investigates long-term patient-reported quality of life for
individuals with low-lying rectal cancers, particularly focusing on the potential impact that …

Rectal cancer is a prevalent disease worldwide. The standard treatment of locally advanced
rectal cancer (LARC) is preoperative chemoradiotherapy followed by surgery and adjuvant …